Saturday 30 October 2021
MSN Laboratories has opened a subsidiary company at Dubai Science Park to expand its geographical footprint into the Middle East.
MSN Group is the fastest-growing research-based pharmaceutical company based out of India. Founded in 2003, the Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA, and Myanmar.
The group has an integrated R&D center for both API and formulation under one roof, dedicated to the research and development of pharmaceuticals. MSN has more than 823 national and international patents, a product portfolio featuring over 450 APIs, and 300+ formulations covering over 35 major therapies.